Improving access to procreative care through affordable hysteroscopic myomectomy

Enhanced access to procreative care resonates with patients and clinicians. This stems from our belief in justice and equity. Ethics teaches us that high-quality healthcare should be a right, and not just a privilege for the economically fortunate few. Our American Society for Reproductive Medicine (ASRM) Ethics Committee guidelines acknowledge this reality by noting, “Economic barriers are the chief contributors to disparities in access to effective treatment” (1). Although acknowledging the need for research on biological causes of infertility, such as fibroids, polycystic ovary syndrome, and azoospermia, these particular guidelines emphasize assisted repro ductive technology (ART) as the solution.

Source: Fertility and Sterility - January 4, 2021 Category: Reproduction Medicine Authors: J. Preston Parry Tags: Reflections Source Type: research